Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial

AIMS/INTRODUCTION: Postmenopausal women receive bisphosphonates for osteoporosis treatment. The effect of these medications on developing diabetes mellitus in prediabetic patients is yet to be investigated. We aimed to determine the effect of alendronate on plasma glucose, insulin indices of postmen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Diabetes Investig
Hlavní autoři: Karimi Fard, Maryam, Aminorroaya, Ashraf, Kachuei, Ali, Salamat, Mohammad Reza, Hadi Alijanvand, Moluk, Aminorroaya Yamini, Sima, Karimifar, Mansoor, Feizi, Awat, Amini, Massoud
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497594/
https://ncbi.nlm.nih.gov/pubmed/30267620
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12944
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky